Raphael Pharmaceutical Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Raphael Pharmaceutical Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2021 to Q3 2024.
  • Raphael Pharmaceutical Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 11, 2024 was 18.7M shares, a 3.31% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 18.7M +599K +3.31% Nov 11, 2024 10-Q 2024-11-14
Q2 2024 18.7M +2.33M +14.3% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 18.7M +2.53M +15.7% Mar 28, 2024 10-K 2024-03-28
Q3 2023 18.1M +2.48M +15.9% Nov 14, 2023 10-Q 2023-11-14
Q2 2023 16.4M +1.14M +7.51% Aug 9, 2023 10-Q 2023-08-09
Q1 2023 16.1M +3.17M +24.4% Mar 25, 2023 10-K/A 2023-05-25
Q3 2022 15.6M Nov 14, 2022 10-Q 2022-11-14
Q2 2022 15.2M Aug 10, 2022 10-Q 2022-08-12
Q1 2022 13M Mar 30, 2022 10-K 2022-03-30
Q4 2021 12.5M Nov 15, 2021 10-Q 2021-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.